Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension
NCT01489670
·
clinicaltrials.gov ↗
COMPLETED
Status
387
Enrollment
INDUSTRY
Sponsor class
Conditions
Glaucoma, Open-Angle
Ocular Hypertension
Interventions
DRUG:
bimatoprost 0.01% ophthalmic solution
Sponsor
Allergan